Silk Road Medical, Inc SILK
Set alert
27.49 0.00 0.00%
At close · Sep 16
27.49 Day range 27.50
52-week range unavailable
- Open
- 27.49
- Prev close
- 27.49
- Mkt cap
- 1.12B
- Vol
- 2.31M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 27.49
- High
- 27.50
- Forward P/E
- -20.98
- Beta
- 1.54
- Short ratio
- 2.48
- Inst. own
- 97.46%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 7, 2024
- 50-d avg
- 27.17
- 200-d avg
- 21.00
- 1y target
- 20.75
2Y chart
Events in this range
- May 9, 2023Earnings: —; estimate -0.39; surprise —%
- Aug 1, 2023Earnings: —; estimate -0.39; surprise —%
- Sep 20, 2023Downgrade: Argus Research · Buy → Hold
- Oct 10, 2023Rating: Piper Sandler · Neutral → Neutral
- Oct 10, 2023Downgrade: CL King · Buy → Neutral
- Oct 10, 2023Downgrade: Citigroup · Buy → Sell
- Oct 10, 2023Downgrade: B. Riley Securities · Buy → Neutral
- Oct 10, 2023Downgrade: Stifel · Buy → Hold
- Nov 8, 2023Earnings: —; estimate -0.36; surprise —%
- Feb 28, 2024Earnings: —; estimate -0.4; surprise —%
- Apr 30, 2024Earnings: —; estimate -0.4; surprise —%
- Aug 7, 2024Earnings: —; estimate -0.38; surprise —%
Signals (82)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Sep 13, 2024 | 2 years ago |
| RSI: Overbought | Sep 13, 2024 | 2 years ago |
| SMA: Bullish | Sep 9, 2024 | 2 years ago |
| SMA: Bearish | Sep 5, 2024 | 2 years ago |
| RSI: Overbought | Aug 9, 2024 | 2 years ago |
| MACD: Sell Signal | Jul 9, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 18, 2024 | 2 years ago |
| RSI: Overbought | Jun 18, 2024 | 2 years ago |
| MACD: Sell Signal | May 28, 2024 | 2 years ago |
| MACD: Buy Signal | Apr 29, 2024 | 2 years ago |
| SMA: Bullish | Apr 22, 2024 | 2 years ago |
| SMA: Bearish | Apr 19, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 12, 2024 | 2 years ago |
| MACD: Buy Signal | Apr 11, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 2, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 20, 2024 | 2 years ago |
| SMA: Bullish | Mar 18, 2024 | 2 years ago |
| SMA: Bearish | Mar 5, 2024 | 2 years ago |
| SMA: Bullish | Mar 4, 2024 | 2 years ago |
| SMA: Bearish | Mar 1, 2024 | 2 years ago |
| SMA: Bullish | Feb 29, 2024 | 2 years ago |
| MACD: Sell Signal | Feb 22, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 16, 2024 | 2 years ago |
| RSI: Overbought | Feb 15, 2024 | 2 years ago |
| MACD: Sell Signal | Feb 12, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 8, 2024 | 2 years ago |
| RSI: Overbought | Feb 6, 2024 | 2 years ago |
| MACD: Sell Signal | Feb 2, 2024 | 2 years ago |
| RSI: Overbought | Feb 1, 2024 | 2 years ago |
| RSI: Overbought | Jan 19, 2024 | 2 years ago |
| RSI: Overbought | Jan 10, 2024 | 2 years ago |
| MACD: Buy Signal | Jan 8, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 5, 2024 | 2 years ago |
| RSI: Overbought | Dec 26, 2023 | 2 years ago |
| SMA: Bullish | Dec 1, 2023 | 2 years ago |
| MACD: Buy Signal | Oct 27, 2023 | 3 years ago |
| MACD: Sell Signal | Oct 11, 2023 | 3 years ago |
| RSI: Oversold | Oct 6, 2023 | 3 years ago |
| RSI: Oversold | Oct 4, 2023 | 3 years ago |
| MACD: Buy Signal | Oct 3, 2023 | 3 years ago |
| RSI: Oversold | Sep 14, 2023 | 3 years ago |
| RSI: Oversold | Sep 12, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 7, 2023 | 3 years ago |
| MACD: Buy Signal | Jul 28, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 12, 2023 | 3 years ago |
| RSI: Oversold | Jul 12, 2023 | 3 years ago |
| MACD: Buy Signal | Jul 11, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 7, 2023 | 3 years ago |
| MACD: Buy Signal | Jun 6, 2023 | 3 years ago |
| RSI: Oversold | Jun 5, 2023 | 3 years ago |
| RSI: Oversold | May 15, 2023 | 3 years ago |
| RSI: Oversold | May 10, 2023 | 3 years ago |
| SMA: Bearish | May 9, 2023 | 3 years ago |
| SMA: Bullish | May 8, 2023 | 3 years ago |
| MACD: Sell Signal | May 4, 2023 | 3 years ago |
| SMA: Bearish | May 2, 2023 | 3 years ago |
| SMA: Bearish | Apr 27, 2023 | 3 years ago |
| SMA: Bullish | Apr 21, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 31, 2023 | 3 years ago |
| RSI: Oversold | Mar 23, 2023 | 3 years ago |
| RSI: Oversold | Mar 10, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 1, 2023 | 3 years ago |
| SMA: Bearish | Feb 28, 2023 | 3 years ago |
| SMA: Bullish | Feb 24, 2023 | 3 years ago |
| MACD: Buy Signal | Feb 22, 2023 | 3 years ago |
| SMA: Bearish | Feb 21, 2023 | 3 years ago |
| SMA: Bullish | Feb 17, 2023 | 3 years ago |
| SMA: Bearish | Feb 6, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 6, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 27, 2023 | 3 years ago |
| MACD: Sell Signal | Jan 25, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 13, 2023 | 3 years ago |
| SMA: Bullish | Jan 10, 2023 | 3 years ago |
| SMA: Bearish | Jan 9, 2023 | 3 years ago |
| SMA: Bullish | Jan 6, 2023 | 3 years ago |
| SMA: Bearish | Jan 5, 2023 | 3 years ago |
| SMA: Bullish | Jan 4, 2023 | 3 years ago |
| SMA: Bearish | Jan 3, 2023 | 3 years ago |
| MACD: Sell Signal | Dec 16, 2022 | 3 years ago |
| MACD: Buy Signal | Dec 13, 2022 | 3 years ago |
| MACD: Sell Signal | Dec 8, 2022 | 3 years ago |
| RSI: Overbought | Nov 16, 2022 | 3 years ago |
Key statistics
- Market cap
- 1.12B
- Enterprise value
- 1.03B
- Trailing P/E
- 0.00
- Forward P/E
- -20.98
- PEG ratio
- -11.77
- Price / sales
- 5.83
- Price / book
- 7.22
- EPS (TTM)
- -1.45
- Beta
- 1.54
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -29.53%
- Revenue (TTM)
- 191.43M
- Revenue growth
- 13.10%
- Free cash flow
- -15.35M
- Total cash
- 171.98M
- Total debt
- 84.47M
- Return on equity
- -36.45%
- Shares outstanding
- 40.63M
- Short % of float
- 7.87%
- 50-day average
- 27.17
- 200-day average
- 21.00
Analyst view
Consensus: hold
Hold
Price target (mean) 20.75 -24.5% downside
Now 27.49
- Target (low)
- 8.00
- Target (mean)
- 20.75
- Target (high)
- 27.50
Ratings (0m) 1 0 buy · 0 hold · 1 sell
- Strong buy0
- Buy0
- Hold0
- Sell0
- Strong sell1
Next earnings
Aug 7, 2024
Expected Aug 7, 2024. Consensus EPS estimate -0.35.
Financials — quick view
SILK Revenue — quarterly 51.24M
SILK Net income — quarterly -16.60M
SILK EPS — quarterly -0.42
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 7, 2024 | Jun 1, 2024 | -0.38 | — | — | — |
| Apr 30, 2024 | Mar 1, 2024 | -0.40 | — | — | — |
| Feb 28, 2024 | Dec 1, 2023 | -0.40 | — | — | — |
| Nov 8, 2023 | Sep 1, 2023 | -0.36 | — | — | — |
| Aug 1, 2023 | Jun 1, 2023 | -0.39 | — | — | — |
| May 9, 2023 | Mar 1, 2023 | -0.39 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 10, 2023 | Piper Sandler | main | Neutral | Neutral |
| Oct 10, 2023 | CL King | down | Buy | Neutral |
| Oct 10, 2023 | Citigroup | down | Buy | Sell |
| Oct 10, 2023 | B. Riley Securities | down | Buy | Neutral |
| Oct 10, 2023 | Stifel | down | Buy | Hold |
| Sep 20, 2023 | Argus Research | down | Buy | Hold |
About Silk Road Medical, Inc
Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California. As of September 17, 2024, Silk Road Medical, Inc operates as a subsidiary of Boston Scientific Corporation.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- silkroadmed.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on SILK — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ANDERSON RICK D | Director | Stock Award(Grant) | Jun 17, 2024 | 11,966 |
| BALLINGER KEVIN J | Director | Stock Award(Grant) | Jun 17, 2024 | 23,666 |
| CARINO TANISHA | Director | Stock Award(Grant) | Jun 17, 2024 | 11,396 |
| CHOU TONY M | Director | Stock Award(Grant) | Jun 17, 2024 | 85,251 |
| DAVIS ANDREW S | Officer | Sale | Jul 2, 2024 | 289,707 |
| KLEMZ KEVIN M | Officer | Sale | Aug 18, 2024 | 162,926 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Wasatch Advisors LP | 13.51% | 5,246,961 | 170.47M | Jun 29, 2023 |
| Vanguard Group Inc | 9.21% | 3,576,239 | 116.19M | Jun 29, 2023 |
| Blackrock Inc. | 7.64% | 2,965,739 | 96.36M | Jun 29, 2023 |
| Capital World Investors | 7.64% | 2,966,730 | 96.39M | Jun 29, 2023 |
| Alliancebernstein L.P. | 6.42% | 2,493,003 | 81.00M | Jun 29, 2023 |
| ClearBridge Investments, LLC | 4.47% | 1,736,607 | 56.42M | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Smallcap World Fund | 7.64% | 2,966,730 | 96.39M | Jun 29, 2023 |
| Legg Mason Clearbridge Small Cap Growth Fd | 3.48% | 1,349,704 | 30.83M | Jul 30, 2023 |
| Vanguard Total Stock Market Index Fund | 2.88% | 1,118,088 | 36.33M | Jun 29, 2023 |
| Wasatch Ultra Growth Fund | 2.52% | 977,595 | 31.76M | Jun 29, 2023 |
| Vanguard Small-Cap Index Fund | 2.45% | 949,918 | 30.86M | Jun 29, 2023 |
| iShares Russell 2000 ETF | 2.26% | 878,220 | 16.97M | Aug 30, 2023 |